CEO: Adelene Q. Perkins

Advent Contact: Shahzad Malik

Chemical genomics-based drug discovery platform

Infinity is a clinical-stage company focused on developing new medicines for the treatment of cancer.

Advent invested in 2002. Infinity listed in 2009 (NASDAQ:INFI).

Back